The Electrocompetent Cells Market is estimated to be valued at US$ 2.07 Bn in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Electrocompetent cells are chemically treated bacterial cells that are capable of taking up extracellular DNA material after being exposed to electric pulses. These cells are commonly used in molecular cloning and other techniques involving genetic transformation of bacterial cells. Some key advantages of electrocompetent cells include higher transformation efficiency, broader host range, and fewer handling requirements compared to chemically competent cells.
Market key trends:
One of the major trends contributing to the growth of the electrocompetent cells market is the rising demand for cloned DNA in various biotechnology and pharmaceutical applications. Cloned DNA obtained through competent cells is widely used in research activities involving gene cloning, site-directed mutagenesis, PCR product cloning and other procedures. Furthermore, advancements in electroporation technology have improved the efficiency and reliability of DNA transformation using electrocompetent cells. This has increased their usage over traditional chemically competent cells. Growing R&D expenditure on genomic research, drug discovery and stem cell therapy is also boosting the demand for competent cell products globally.
Porter’s Analysis
Threat of new entrants: Electrocompetent Cells Market is capital-intensive to enter due to high degree of technical knowhow and R&D required. This creates moderate threat of new entrants.
Bargaining power of buyers: The presence of many established players makes buyers have moderate bargaining power as they can choose from various options available in the market.
Bargaining power of suppliers: Established suppliers have some bargaining power over price and supply of raw materials due to specialized nature of materials required however this power is balanced due to availability of substitutes.
Threat of new substitutes: There exists low threat of substitution since electrocompetent cells have unique applications that are difficult to be replicated by other solutions.
Competitive rivalry: High due to presence of many global and regional players competing on basis of product quality, reliability and pricing.
SWOT Analysis
Strength: Wide product portfolios and geographic presence of key players. Growing life sciences industry driving demand.
Weakness: High capital requirement for R&D, production and compliance. Dependency on limited raw material suppliers.
Opportunity: Rising drug discovery and biological research activities presenting lucrative growth opportunities. Untapped potential in emerging economies.
Threats: Stringent regulatory environment increasing compliance costs. Threat from open innovation challenging patents.
Key Takeaways
The global Electrocompetent Cells Market is expected to witness high growth, exhibiting CAGR of 10% over the forecast period, due to increasing demand for cloning and transformation applications in biopharmaceutical industry. The market size is projected to reach US$ 4.29 billion by 2030 from US$ 2.07 billion in 2023.
Regional analysis: North America dominates Electrocompetent Cells Market currently and is expected to continue its dominance over forecast period owing to presence of major players and growing biotechnology industry in the region. Asia Pacific exhibits fastest growth during forecast period led by rising economies like India and China expanding their biopharmaceutical manufacturing capabilities.
Key players operating in the Electrocompetent Cells Market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies, Inc., QIAGEN N.V., New England Biolabs, Inc., GenScript Biotech Corporation, Lucigen Corporation, Takara Bio Inc., Delphi Genetics S.A., IBA GmbH, Scarab Genomics LLC, Zymo Research Corporation, Bioline GmbH (Meridian Bioscience), SelectScience, Biosearch Technology. The market is consolidated in nature with top players accounting for major share.
A new business intelligence report released by AMA Research with title "Electrocompetent Cells Market Insights, Forecast to 2026" provides latest updates and strategic steps taken by competition along with growth estimates of market size.
If you have a different set of players/manufacturers according to geography or needs regional or country segmented reports we can provide customization according to your requirement.
This study mainly helps understand which market segments or Region or Country they should focus in coming years to channelize their efforts, understanding current investments cycle and impact of COVID-19 and slowdown.
The report presents the market competitive landscape and in depth analysis of the major vendor/key players in the market along with their strategies to overcome production cycle issue and supply chain management to make process efficient.
The Electrocompetent Cells Market segments and Market Data Break Down are illuminated below: by Type (Cloned Competent Cells, Agrobacterium tumefaciens Competent Cells, Expression Competent Cells), Application (Subcloning & Routine Cloning, Phage Display Library Construction, Toxic/Unstable Dna Cloning, High-Throughput Cloning, Protein Expression, Mutagenesis, Single-Stranded Dna Production, Bacmid creation, Cre-lox recombination (PIR1/PIR2)), Phases (Lag Phase, Log Phase, Stationary Phase, Death Phase), End User (Pharmaceutical and Biotechnology Companies, Academic Research Institutes, Contract Research Organizations (CROs)) Furthermore, the years considered for the study are as follows: Historical year – 2015-2020 Base year – 2020 Forecast period** – 2021 to 2026 [** unless otherwise stated] **Moreover, it will also include the opportunities available in micro markets for stakeholders to invest, detailed analysis of competitive landscape and product services of key players.
Region Included are: North America, Europe, Asia Pacific, Oceania, South America, Middle East & Africa Country Level Break-Up: United States, Canada, Mexico, Brazil, Argentina, Colombia, Chile, South Africa, Nigeria, Tunisia, Morocco, Germany, United Kingdom (UK), the Netherlands, Spain, Italy, Belgium, Austria, Turkey, Russia, France, Poland, Israel, United Arab Emirates, Qatar, Saudi Arabia, China, Japan, Taiwan, South Korea, Singapore, India, Australia and New Zealand etc.
